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Plague Epidemic 
in the Kingdom of 
Naples, 1656–1658
To the Editor: In 1656, an 
epidemic of plague occurred in the 
Kingdom of Naples, Italy. Earlier the 
disease had spread from Algiers to 
Spain; in June 1647, it appeared in 
Valencia, and in the spring of 1648, 
it appeared in Aragon and several 
other Spanish areas of Valencia, 
Andalusia, and Catalonia. In 1652, 
plague had spread to Sardinia and 
then to the cities and territories of 
Naples, Rome, and Genoa. Within 
the Kingdom of Naples, plague fi rst 
reached the town of Naples in the 
spring of 1656. Despite measures 
restricting population movement, by 
the summer of 1656, the disease had 
reached several provinces in southern 
Italy (1,2).
Historical records indicate that 
the epidemic in Barletta, in southern 
Italy, developed after the arrival of 
a ship from Naples. On May 26, 
1656, the ship Sant’ Andrea arrived 
from Naples at the port of Barletta. 
However, after sanitary inspection, 
the ship was prevented from landing 
and obliged to depart, but this measure 
was not suffi cient to prevent the 
disease from entering the port. The 
Barletta epidemic peaked in October, 
after which the number of cases 
diminished; and on June 22, 1657, 
Barletta was declared free of plague. 
Of this city’s original population of 
20,000, the disease killed 7,000–
12,000 persons. It is hypothesized that 
throughout the Kingdom, the plague 
killed ≈1,250,000 persons (1,2).
Since the 14th century, noble 
families of Barletta had been buried in 
tombs in underground tunnels of Sant’ 
Andrea church. During restoration of 
the church in 2009, more underground 
tunnels containing many skeletons 
were discovered. It has been 
hypothesized that the church had also 
been used as a cemetery during the 
plague epidemic. During an inspection 
of the skeletons, 5 skulls of young 
persons were identifi ed and collected. 
For a negative control, the skull of a 
person buried in a tomb before the 
epidemic was also collected.
The skulls were radiographed 
to identify unerupted teeth (Figure), 
which were then aseptically extracted. 
After classifi cation, each tooth was 
cut along a sagittal line to uncover the 
dental pulp, which was then hydrated 
in sterile phosphate-buffered saline 
(pH 7.2) for 48 h at 37°C. The DNA 
was extracted by using DNAeasy 
Blood and Tissue Kits (QIAGEN, 
Hilden, Germany) and by modifying 
the fi rst step, which was conducted 
overnight at 56°C with 600 μL of 
ATL buffer (QIAGEN) and 50 μL of 
proteinase K. To verify the presence of 
inhibiting substance, the control DNA 
extracts were screened by using a PCR 
for human mitochondrial DNA (3).
To investigate the cause of the 
deaths, we adopted a PCR suicide 
method and searched for Yersinia 
pestis. We amplifi ed the pla gene for Y. 
pestis by using Sybr green PCR in real 
time with a modifi cation of a previous 
protocol (4) coupled with conventional 
PCR according to Drancourt et al. (5). 
Conventional PCRs were adopted 
for Bacillus anthracis by targeting 
the pag and capC genes (6) and for 
Salmonella enterica serovar Typhi by 
targeting the narG gene (7). To prevent 
cross-contamination, we conducted 
all PCRs with a negative control and 
in the absence of positive controls. 
Melting curve analysis and agarose 
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gel electrophoresis of PCR products 
indicated suspected positive samples. 
All amplicons relative to conventional 
and suicide PCR were submitted for 
sequencing analysis confi rmation. 
The negative DNA was reanalyzed to 
confi rm the results.
From the 26 dental pulp samples 
analyzed from the 5 skulls of young 
persons, 7 samples were positive 
for the pla gene of Y. pestis by the 
Sybr green real-time PCR, and 2 of 
these were positive for this gene by 
conventional PCR. All were negative 
for B. anthracis and S. enterica ser. 
Typhi. GenBank BLAST (www.ncbi.
nlm.nih.gov/blast/Blast.cgi) results 
of the 2 sequenced amplicons found 
a 100% match with the reference 
sequences (GenBank accession no. 
AL109969.1); query coverage was 
100%. The sequences obtained were 
deposited in the GenBank sequence 
database under accession nos. 
JN208020–1.
In conclusion, the confi rmed 
fi nding of DNA of Y. pestis in 2 
skeletons and suspected fi nding in 
the remaining 3 suggests that these 
persons died of plague during the 
1656–1658 epidemic in southern Italy. 
Although it has not been universally 
agreed upon, several studies have 
confi rmed that the agent of 16th to 18th 
century “plague” epidemics in Europe 
were caused by Y. pestis. Different 
methods have documented Y. pestis 
as the agent in 10 Black Death burial 
sites scattered over 5 countries (8). In 
northern Italy, the presence of Y. pestis 
has been confi rmed in Venice (14th–
17th centuries) (8), Genoa (Bastione 
dell’Acquasola) (14th century) (9), 
and Parma (16th–17th centuries) (10). 
This study confi rms that the plague 
that infected the Kingdom of Naples, 
which spanned almost all of southern 
Italy, was also caused by Y. pestis.
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Figure. Radiograph of skull found under Sant’ Andrea church in Barletta, Italy, in 2009, 
showing unerupted teeth (circled) that were later extracted aseptically.
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To the Editor: During recent 
decades, a considerable and consistent 
decrease in worldwide incidence of 
leprosy has been observed, mainly 
because of the recommendation to 
introduce multidrug therapy in 1981 
(1) and the implementation of free 
therapy in 1994 (2) by the World 
Health Organization (WHO). The 
prevalence rate of the disease has 
been reduced globally by >90% since 
1985 (3). Since 2000, WHO has 
recommended the implementation of a 
leprosy surveillance system in leprosy-
endemic countries with indicators for 
screening, treatment, and monitoring 
of patients (4). From these indicators, 
WHO establishes an annual offi cial 
report on the global status of the 
disease. According to offi cial reports 
received from 141 countries, the 
global registered prevalence of leprosy 
was 211,903 cases in 2010 (5).
La Réunion is a French overseas 
department located in the Indian 
Ocean 700 km east of Madagascar. 
La Réunion’s health care system is 
similar to that of continental France. 
Although new cases of leprosy have 
been punctually reported by health 
professionals during the past few years, 
which suggests that the disease is still 
present, the situation in La Réunion 
is poorly documented because of the 
lack of a specifi c surveillance system. 
Thus, the goal of eliminating leprosy 
as a public health problem (i.e., 
prevalence <1/10,000) (6) cannot be 
assessed because the goal requires a 
good knowledge of the epidemiologic 
status of the disease. Furthermore, 
the risk of leprosy recrudescence 
linked to a relapse of patients with 
autochthonous cases or patients with 
leprosy migrating from neighboring 
leprosy-endemic countries, such as 
Madagascar, Comoros, and Mayotte 
(5), is present. In 2009, a total of 1,572 
new cases of leprosy were detected in 
Madagascar, 319 in Comoros, and 37 
in Mayotte (5,7). If one considers the 
geographic proximity and the many 
tourist exchanges between La Réunion 
and those neighboring islands, the 
risk of importation, although low, is 
constant. 
In that context, Cire Indian Ocean 
(the Regional Offi ce of French Institute 
for Public Health Surveillance), in 
collaboration with health professionals 
involved in diagnosis and treatment of 
the disease, has implemented a specifi c 
surveillance system for leprosy in 
La Réunion. The objectives are to 
guide potential preventive measures 
by determining incidence of leprosy, 
following the disease’s evolution, and 
characterizing the patients affected.
The surveillance system was 
based on the notifi cation of every 
case by health professionals likely to 
diagnose and treat subjects according 
to the WHO case defi nition (8), 
i.e., clinicians, private or hospital 
dermatologists, and infectious 
disease specialists. The notifi cation 
was realized through a standardized 
questionnaire that included 
sociodemographic, clinical, and 
microbiological data. Concurrently, 
the pathology laboratories were 
consulted to detect any nondeclared 
cases and to improve the completeness 
of data.
This surveillance was 
retrospective for 2005–2010, then 
prospective for 2011. In total, 17 
patients responding to the case 
defi nition of leprosy and given a 
diagnosis during 2005–2010 were 
reported for an average population 
of 804,025 inhabitants in La Réunion 
(data from the National Institute of 
Statistics and Economics Studies). 
The mean annual incidence during 
this period was 3.4 cases/106 
inhabitants. The male:female sex 
ratio was 2.2, and the median age was 
54 years (range 8–77 years). More 
than half the patients were born in La 
Réunion (n = 9); the other patients’ 
birthplaces were Comoros Islands (n 
= 4), Mayotte (n = 3), and Madagascar 
(n = 1). Among the patients born 
in La Réunion, 6 had never left the 
island, 3 had traveled but had always 
resided in La Réunion, and 6 patents 
resided in the same area of a city in 
the southwestern part of the island.
An active search for other 
cases in this area was performed by 
contacting all the health professionals 
likely to diagnose leprosies; 1 
clinician reported a suspected case 
among his patients. That patient is 
currently being screened. Of the 
patients overall, 15 were screened 
by skin biopsy or smear from the ear. 
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